Innovative Phase Contrast Imaging
For Early Diagnosis of Breast Cancer




Towards a New Semiology of Breast Microcalcifications 
to avoid Millions of Unnecessary Macrobiopsies

Early Diagnosis of Breast Cancer
Challenged by a large uncertainty on Positive Predictive Value in ACR 4 category (2% - 95%)


Leads to overconsumption of Macrobiopsies which are :
  •  Deleterious for the patient
  •  Time-consuming for the doctor 
  •  Costly for the Health System
First clinical evaluation results
We have performed a first clinical evaluation on fifty breast Macro-Biopsies

Our Phase contrast imaging technique demonstrates better performances than classic absorption technique and the main interest of these results is that our phase contrast images allow radiologists to easily characterize microcalcifications into benign and malignant directly on the Mammograms.
Products under Development...
Based on Phase Contrast Imaging Technique

A.BAKKALI

CEO

PhD in Nuclear Medical Imaging. HEC, Corporate Management and Finance.

N.TAMDA

Market Strategy Director

PhD in Nuclear Medical Imaging Business Development Expertise

B.Appert-Collin

CEO of ALPHANOV

S.BUCOURT

CEO of Imagine Optic

S.REGNAULT

Chairman of Vygon

Take part of the New GOLD STANDARD
Join us

  • 1 Rue François Mitterrand, 33400 Talence, France
  •  Mon-Fri - 08:00-19:00